277 related articles for article (PubMed ID: 23381342)
21. Neurofibromatosis 2.
Hoa M; Slattery WH
Otolaryngol Clin North Am; 2012 Apr; 45(2):315-32, viii. PubMed ID: 22483819
[TBL] [Abstract][Full Text] [Related]
22. A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma.
Chu YW; Cheuk DK; Chung BH; Bowers NL; Ha SY; Chiang AK; Chan GC
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406210
[TBL] [Abstract][Full Text] [Related]
23. Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.
Pathmanaban ON; Sadler KV; Kamaly-Asl ID; King AT; Rutherford SA; Hammerbeck-Ward C; McCabe MG; Kilday JP; Beetz C; Poplawski NK; Evans DG; Smith MJ
JAMA Neurol; 2017 Sep; 74(9):1123-1129. PubMed ID: 28759666
[TBL] [Abstract][Full Text] [Related]
24. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
25. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases.
Ferrer M; Schulze A; Gonzalez S; Ferreiro V; Ciavarelli P; Otero J; Giliberto F; Basso A; Szijan I
Neurosci Lett; 2010 Aug; 480(1):49-54. PubMed ID: 20553997
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromatosis 2 in the pediatric age group.
Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
[TBL] [Abstract][Full Text] [Related]
28. Spinal tumors in neurofibromatosis-2: management considerations - a review.
Holland K; Kaye AH
J Clin Neurosci; 2009 Feb; 16(2):169-77. PubMed ID: 19101145
[TBL] [Abstract][Full Text] [Related]
29. Unilateral Laminectomy Approach for the Removal of Spinal Meningiomas and Schwannomas: Impact on Pain, Spinal Stability, and Neurologic Results.
Pompili A; Caroli F; Crispo F; Giovannetti M; Raus L; Vidiri A; Telera S
World Neurosurg; 2016 Jan; 85():282-91. PubMed ID: 26475380
[TBL] [Abstract][Full Text] [Related]
30. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
Baser ME; Makariou EV; Parry DM
J Neurosurg; 2002 Feb; 96(2):217-22. PubMed ID: 11838793
[TBL] [Abstract][Full Text] [Related]
31. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
32. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
J Neurosurg; 2020 May; 134(5):1377-1385. PubMed ID: 32442973
[TBL] [Abstract][Full Text] [Related]
33. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
34. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
36. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.
Bosch MM; Boltshauser E; Harpes P; Landau K
Am J Ophthalmol; 2006 Jun; 141(6):1068-1077. PubMed ID: 16765675
[TBL] [Abstract][Full Text] [Related]
37. Frequency of the Loss of Heterozygosity of the
DE Carvalho RM; DE Castro Sant' Anna C; Pinto GR; Paschoal EHA; Tuji FM; DO Nascimento Borges B; Soares PC; Júnior AGF; Rey JA; Chaves LCL; Burbano RR
Anticancer Res; 2018 Apr; 38(4):2149-2154. PubMed ID: 29599333
[TBL] [Abstract][Full Text] [Related]
38. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
[TBL] [Abstract][Full Text] [Related]
39. Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(6):367-72. PubMed ID: 26652870
[TBL] [Abstract][Full Text] [Related]
40. Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition Syndromes.
Hannan CJ; Hammerbeck-Ward C; Pathmanaban ON; Smith MJ; Rutherford SA; Lloyd SK; Mackenzie Freeman SR; Wallace AJ; King AT; Richard Evans DG
Neurosurgery; 2022 Jun; 90(6):793-799. PubMed ID: 35343466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]